Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
Heart drug aficamten tested for Long-Term safety in 900 patients
Disease control ENROLLING_BY_INVITATIONThis study follows 900 people with hypertrophic cardiomyopathy who have already taken aficamten in earlier trials. Researchers want to see if the drug is safe and tolerable over a longer period. Participants take aficamten tablets daily, with regular clinic visits to monitor for …
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New heart drug aficamten aims to boost exercise and quality of life in HCM patients
Symptom relief OngoingThis phase 3 trial tests whether aficamten, an oral drug, can improve quality of life and exercise capacity in 500 adults with symptomatic non-obstructive hypertrophic cardiomyopathy, a heart condition that makes the heart muscle thick and stiff. Participants receive either afica…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC